
Prescription-grade CBD may help control hard-to-treat seizures caused by a rare genetic disorder, a preliminary study suggests. The study involved 224 patients with tuberous sclerosis complex (TSC) — a genetic condition that affects about one in 6,000 people, according to the U.S. National Institutes of Health. It causes noncancerous tumors to arise throughout the body,… read on >